Clonidine HCl 0.232%/Deoxy D-Glucose 0.5%/Gabapentin 6%/Ketamine HCl 11.5%/Lidocaine HCL 5% Topical Gel

This formulation is a compounded topical gel containing Clonidine HCl 0.232%, Deoxy D-Glucose 0.5%, Gabapentin 6%, Ketamine HCl 11.5%, and Lidocaine HCL 5%. It is a semisolid formulation that is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency of the formulation ensures that the active ingredients are absorbed effectively into the skin for targeted treatment.

Clonidine HCl is a medication that is primarily used to treat high blood pressure, but in this formulation, it is used for its potential analgesic and anti-inflammatory properties. Deoxy D-Glucose is a glucose analog that is included in the formulation for its potential to enhance the effectiveness of the other active ingredients. Gabapentin is a medication that is commonly used to treat nerve pain and seizures, and in this formulation, it is used for its analgesic properties. Lidocaine HCL is a local anesthetic that is used in this formulation to provide immediate and localized pain relief.

This formulation is designed to treat a variety of disease states that involve pain and inflammation. It can be used to manage conditions such as neuropathic pain, post-herpetic neuralgia, fibromyalgia, and other conditions that involve chronic pain.

It is important to note that this is a compounded medication, which means it is made specifically for each individual patient based on their specific needs and the prescription provided by their healthcare provider. As such, the effectiveness and safety of this formulation can vary between individuals. If you have any questions about this formulation, or if you are a healthcare provider considering prescribing this formulation, please reach out to us. We are a team of knowledgeable compounding pharmacists at Bayview Pharmacy, and we are here to help.

This compounded formulation contains several active ingredients, each with its own potential for drug interactions. Clonidine HCl, a medication primarily used to treat high blood pressure, can interact with other antihypertensive drugs and enhance their effects, leading to a risk of hypotension. It can also interact with CNS depressants, potentially enhancing their sedative effects. Patients should be advised to avoid alcohol while using this formulation.

Deoxy D-Glucose, a glucose analog, is not typically associated with significant drug interactions. However, it may affect glucose metabolism and could potentially interact with antidiabetic medications. Patients with diabetes should monitor their blood glucose levels closely while using this formulation.

Gabapentin, a medication used to treat nerve pain and seizures, can interact with antacids, reducing its absorption and effectiveness. It is recommended to take gabapentin at least 2 hours after taking an antacid. Gabapentin can also enhance the effects of CNS depressants, including opioids, antihistamines, and alcohol, potentially leading to increased sedation and respiratory depression.

Ketamine HCl, an anesthetic, can interact with other CNS depressants, potentially enhancing their effects and increasing the risk of respiratory depression. It can also interact with monoamine oxidase inhibitors (MAOIs), potentially leading to a hypertensive crisis. Patients should be advised to avoid alcohol and other CNS depressants while using this formulation.

Lidocaine HCl, a local anesthetic, is not typically associated with significant drug interactions. However, it can interact with other local anesthetics and antiarrhythmic drugs, potentially leading to additive systemic toxicity. Patients should inform their healthcare provider if they are using any other local anesthetics or antiarrhythmic drugs.

This formulation is designed to treat a variety of disease states. Clonidine can help with withdrawal symptoms from opioids and can also have a synergistic effect with other pain medications to provide better pain control. Deoxy D-Glucose is included for its potential anticancer effects, although more research is needed in this area.

As with any medication, it is important for patients and prescribers to be aware of potential drug interactions and to monitor for any adverse effects. If you have any questions about this formulation or its potential interactions, please do not hesitate to reach out to us at Bayview Pharmacy.

This unique formulation combines several active ingredients, each with its own mechanism of action, to provide a comprehensive approach to pain management. The gel is designed to be applied topically, directly to the area of pain, allowing for targeted treatment and absorption of the active ingredients.

Clonidine HCl is a medication that is primarily used to treat high blood pressure, but it also has pain-relieving properties. It works by stimulating alpha-2 adrenergic receptors in the brain, which helps to reduce nerve signal transmission and thus decrease pain. The concentration of Clonidine HCl in this formulation is 0.232%.

Deoxy D-Glucose at a concentration of 0.5% is included in the formulation for its potential to interfere with the metabolism of nerve cells, thereby reducing the transmission of pain signals. It is a glucose analog that is taken up by glucose-transporting proteins but is not further metabolized, which can lead to a decrease in cellular activity.

Gabapentin, present at a concentration of 6%, is a medication that is commonly used to treat nerve pain. It works by affecting the way the nerves send messages to your brain, thereby reducing the perception of pain.

Ketamine HCl, at a concentration of 11.5%, is a powerful anesthetic that works by blocking the NMDA receptor, a type of glutamate receptor in the brain and spinal cord that is involved in pain transmission. By blocking this receptor, Ketamine HCl can provide significant pain relief.

Lidocaine HCl, present at a concentration of 5%, is a local anesthetic that works by blocking sodium channels in the nerve cells, preventing the initiation and conduction of nerve impulses. This results in a numbing effect, providing immediate relief from pain.

The combination of these ingredients in a gel formulation allows for easy and precise application, with the active ingredients being absorbed directly into the skin for targeted treatment. This formulation can be used to treat a variety of disease states that involve pain, including neuropathic pain, post-herpetic neuralgia, and complex regional pain syndrome. As always, if you have any questions about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. We are a team of knowledgeable compounding pharmacists and we are here to help.

This formulation of Clonidine HCl 0.232%/Deoxy D-Glucose 0.5%/Gabapentin 6%/Ketamine HCl 11.5%/Lidocaine HCL 5% Topical Gel is noted for its analgesic and anti-inflammatory properties. Its key active ingredients function synergistically to offer relief from various pain conditions. It is most commonly used for the management of neuropathic pain conditions such as post-herpetic neuralgia, peripheral neuropathy, and trigeminal neuralgia. Additionally, it can effectively manage symptoms in patients with fibromyalgia and other forms of chronic pain.

Aside from its prominent use against pain, there are potential other uses for this topical gel. The inclusion of Clonidine, a medication approved for hypertension, may help mitigate the body's response to stress in patients with conditions such as tics, Tourette syndrome, or hot flashes due to menopause. Additionally, this medication's ability to penetrate the dermal layer might also present a possible application in minimizing symptoms of withdrawal in patients undergoing treatment for opioid dependence, though further research is necessary.

The gabapentin component of the gel has been shown to have an effect on seizures in certain individuals, and its topical administration may reduce some systemic side effects associated with its oral use. While this would not typically be a first-line treatment for such conditions, it may provide added benefit for patients with hard-to-control seizures, especially if they also suffer from neuropathic pain.

Though not a primary indication, the Ketamine HCl component in the formulation could potentially prove beneficial for some psychiatric conditions such as treatment-resistant depression and post-traumatic stress disorder (PTSD), considering its NMDA receptor antagonist property.

It should be noted that these are potential additional uses for the components individually. The formulation as a whole is designed and optimized primarily as a topical analgesic and anti-inflammatory gel for the management of neuropathic and chronic pain. Use of this formulation for any other purposes should always be under the direction of a healthcare provider. It is crucial to recognize the multi-faceted benefits this medication has to offer, but it is equally important to use it responsibly. Understanding the diverse potential uses of this distinct formulation can allow prescribers to custom-fit therapeutic regimens to patients' specific needs.

We encourage any patient or prescriber with more detailed questions about this formulation to reach out to us for a more in-depth consultation regarding its use.